Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
2.14%2.24%17.43x1.49x2.62x9.42x14.49x 56.2B
2.63%2.96%21.73x1.37x2.03x8.86x11.79x 7.58B
-.--%0.1%44.7x10.87x10.59x33.38x36.06x 5.34B
0.5%0.5%60.71x3.55x3.24x37.51x58.22x 4.99B
-.--%-.--%77.78x - - - - 3.09B
0.81%1.03%32.79x3.04x5.6x18.45x31.54x 2.72B
2.61%2.71%17.15x1x1.49x39.34x-74.86x 1.21B
1% - 12.67x1.55x - - - 1.14B
Average 1.21% 1.36% 35.62x 3.27x 4.26x 24.49x 12.87x 10.28B
Weighted average by Cap. 1.81% 1.94% 24.93x 2.29x 3.24x 13.58x 17.71x
Specialty & Advanced Pharmaceuticals
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW